Gogakos, Tasos

Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression

Lama, L., Adura, C., Xie, W., Tomita, D., Kamei, T., Kuryavyi, V., Gogakos, T., Steinberg, J. I., Miller, M., Ramos-Espiritu, L., et al. (2019) · Nature Communications

interferon and immune responsesPhosphodiesterase function and regulation

Cited by 303

Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers

Akat, K. M., Moore-McGriff, D., Morozov, P., Brown, M., Gogakos, T., Correa Da Rosa, J., Mihailovic, A., Sauer, M., Ji, R., Ramarathnam, A., et al. (2014) · Proceedings of the National Academy of Sciences

MicroRNA in disease regulationCardiac Fibrosis and Remodeling

Cited by 254

Characterizing expression and processing of precursor and mature human tRNAs by hydro-tRNAseq and PAR-CLIP

Gogakos, T., Brown, M., Garzia, A., Meyer, C., Hafner, M., & Tuschl, T. (2017) · Cell Reports

RNA and protein synthesis mechanismsRNA modifications and cancer

Cited by 209

Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital

Miller, T. E., Garcia Beltran, W. F., Bard, A. Z., Gogakos, T., Anahtar, M. N., Astudillo, M. G., Yang, D., Thierauf, J., Fisch, A. S., Mahowald, G. K., et al. (2020) · The FASEB Journal

SARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies

Cited by 148

Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism

Stefely, J. A., Christensen, B. B., Gogakos, T., Cone Sullivan, J. K., Montgomery, G. G., Barranco, J. P., & Van Cott, E. M. (2020) · American Journal of Hematology

COVID-19 Clinical Research StudiesBlood Coagulation and Thrombosis Mechanisms

Cited by 80